Aurion Biotech, Inc. (AURN)

Aurion Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022
Debt / Equity Ratio	-0.28	-0.04	-0.06
Debt / EBITDA Ratio	-1.04	-0.14	-0.22
Debt / FCF Ratio	-1.19	-0.16	-0.23
Quick Ratio	3.54	4.48	2.03
Return on Equity (ROE)	27.17%	25.75%	26.34%
Return on Assets (ROA)	-	-86.58%	-117.68%
Return on Capital (ROIC)	38.21%	27.83%	27.06%
Return on Capital Employed (ROCE)	409.37%	-109.14%	-170.49%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).